Re: $$ for Doctors

[Guest guest]

Interesting. Personally I am not all that troubled by some aspects of

these relationships. In any case, the transparency is definitely a plus.

That having been said, i did a search for some of the leading CLL

specialists. I noticed that the thing they had in common was payments by

GlaxoKline.

I then searched for GlaxoKline + CLL. The results came up with

mentions of Arzerra/Genmab - which looks like it was approved in Oct 2009.

So my question is... what's up with this drug? Why don't we see more

mention of it here on the list? Just curious....

On 1/19/2011 5:22 PM, cllcanada wrote:

>

> Check out Dollars for Docs on Pro Publica. Numerous articles and there

> is a database

> where you can find out who is paying your favourite doctor in the U.S.

> Drug companies are required to disclose this, however a few are

> holding out...

>

> This law was passed in 2009

> Physician Payments Sunshine Act of 2009

> http://thomas.loc.gov/cgi-bin/query/z?c111:S.301.IS:

>

> Try your search on the right of this page. Dollars for Docs

> http://www.propublica.org/topic/dollars-for-doctors

>

> Also see:

>

>

http://www.propublica.org/article/profiles-of-the-top-earners-in-dollar-for-docs

>

> ~chris

>

>

--

M: 484-802-7867

[Guest guest]

A rose is a rose is a drug named ofatumumab .. doesn't really roll off the

tongue. Next generation rituxan? No mouse involved and there are a number of

trials combining it with older and new drugs, as far as I can see.

(Hope I spelled it right)

Lynn

(sorry to be posting so much today .. just one of those days, I guess.)

>

> I then searched for GlaxoKline + CLL. The results came up with

> mentions of Arzerra/Genmab - which looks like it was approved in Oct 2009.

>

> So my question is... what's up with this drug? Why don't we see more

> mention of it here on the list? Just curious....

>

>